Ortho Phthalaldehyde is a chemical compound used as a disinfectant and sterilant in healthcare facilities, laboratories, and other industries. The market is expected to witness significant growth in the coming years, driven by increasing demand from healthcare facilities, the rising prevalence of hospital-acquired infections (HAIs), and advancements in technology.
Ortho Phthalaldehyde (OPA) is widely used as a disinfectant and sterilizer in healthcare facilities to prevent the spread of infections. The increasing number of surgeries and medical procedures performed worldwide is driving the growth of OPA as a sterilant. Moreover, HAIs are a significant cause of morbidity and mortality worldwide, and effective disinfection of medical equipment and surfaces is crucial in preventing their spread. OPA is known for its broad-spectrum antimicrobial activity and is highly effective against a wide range of microorganisms, making it an attractive option for healthcare facilities in the prevention of HAIs.
Furthermore, the development of new and advanced technologies for its production is driving down the cost of production, making it a more cost-effective alternative to traditional disinfectants like glutaraldehyde. For instance, advances in catalysis technology have enabled the development of more efficient and sustainable methods for the synthesis of Ortho Phthalaldehyde reducing the cost of production.
The Ortho phthalaldehyde market is broadly segmented into application and end-user industries. The application segment is further categorized as amino acids & detection and quantization of high-pressure liquid chromatography. The end-user industries segment is further subdivided into biochemistry, disinfection, testing, polymerization, isomeric han LT hides in winemaking, organic synthesis, and others.
Some of the key players operating in this market are AK Scientific Inc, MP BIOMEDICALS,Virox, TCI America, and others. Prominent players involved in the marketplace are continuously focusing on business expansion activities through collaborations and partnerships across the value chain. For instance, in 2019 Metrex Research, LLC announced the acquisition of Virox., a leading manufacturer of disinfectants and sterilants, including OPA. With this acquisition, the company expanded its product portfolio to meet the growing consumer demand in this market.
The Ortho Phthalaldehyde market in Asia Pacific is expected to experience significant growth in the coming years owing to increasing demand for healthcare services, rising awareness about the importance of infection control, and increasing investments in medical infrastructure.